FDA Inspection
Elevate SurgicalElevate Surgical – FDA Inspection, Mar 4, 2019
Record Details
This FDA Inspection record concerns Elevate Surgical, with an inspection on March 4, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 69d715d3-2561-4f47-addc-33a50c487a36
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1081171
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 1271.260(b)Storage temperatures appropriate
- 21 CFR 1271.270(d)Retention time (10 year rules)
- 21 CFR 1271.160(b)(1)Ensuring appropriate core requirements followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Elevate Surgical
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 23, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 6, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Elevate Surgical
- FDA Inspection 1277232 - 2025-07-23
- FDA Inspection 903685 - 2014-11-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.